Background Trinitrobenzenesulfonic acid (TNBS)-induced colitis is one of the most widely used experimental colitis models. However, there is no standard procedure for inducing colitis by TNBS because it is difficult to achieve a uniform distribution of colitis. We have developed a modified method of murine TNBS-induced colitis that involves inhalation anesthesia with sevoflurane combined with both single and repeated TNBS administrations. Aims To compare the usefulness of our newly developed method for inducing murine TNBS-induced colitis with that of conventional intraperitoneal anesthesia. Methods TNBS in ethanol was administered to C57BL/6J mice held in an inverted vertical position either under continuous inhalation anesthesia with sevoflurane, in accordance with our newly developed method, or by intraperitoneal injection with 2.5 % avertin, in accordance with the conventional procedure. Body weight change, cytokine profile, and histological findings were examined during the course of colitis. Results The dispersion of anesthesia time, TNBS retention time, and nadir weight during the course of colitis was decreased using the newly developed method compared with the conventional procedure. Optimization of the modified TNBS-induced colitis, as evidenced by the predominant expression of Th1 and Th17 cytokines on day 7, was attained by the injection of 2.25 mg TNBS in 55 % ethanol. Regulation of the TNBS retention time using inhalation anesthesia with sevoflurane allowed strict control of the disease severity of TNBS-induced colitis. Using the modified method we were also able to develop a chronic TNBS-induced colitis model by repeated TNBS administration without excessive mortality of the mice. Conclusions Our modified method for murine TNBSinduced colitis using continuous inhalation anesthesia with sevoflurane provides a better experimental colitis model following both single and repeated TNBS administrations.
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Introduction
Animal models, such as chemically induced, genetically manipulated, and immune-mediated models of gut inflammation, are indispensable for studying the pathogenesis of inflammatory bowel diseases (IBD) and the effect of therapies on colonic inflammation [1] [2] [3] [4] . One of these models, namely, chemically induced colitis, has been widely used because the onset of inflammation is immediate, the procedure is relatively straightforward, and the method can be coupled with other models, such as genetically manipulated models [5] . One of the most widely used chemically induced models is the administration of the haptenating agent 2,4,6-trinitrobenzenesulfonic acid (TNBS) because it decreases the barrier function of the mucosa, resulting in innate and somehow acquired immune responses [6] . It is thought that this model resembles Crohn's disease because of the resulting mucosal inflammation mediated by a Th1 response with excessive proinflammatory cytokine production, including interferon gamma (IFN-c), tumor necrosis factor alpha (TNF-a), and interleukin (IL)-12 [7] [8] [9] .
Although the TNBS model is widely used, there is no standard procedure to induce TNBS colitis [6] , and procedures reported in the literature often differ in terms of genetic background and age of the experimental animals, dose and frequency of TNBS administration, percentage of added ethanol, and the time of death [6] . These differences may influence the outcomes of studies using the model [10] . Therefore, researchers have to set up the most suitable conditions in their respective facility to gain acceptable homogeneity and reproducibility, which in turn results in differences in the protocols reported in published studies. In addition, to date, there have been few studies in which TNBS has been administered repeatedly. In the TNBS model, TNBS needs to be dosed very carefully in order to avoid mortality among the mice [6, [11] [12] [13] , and individual optimization of administered TNBS is required, particularly in generating chronic colitis [5] . One probable explanation for why it is so difficult to establish the optimized condition is that the effective dose can also cause death in this setting. In addition to this problem, the influence of anesthesia on this outcome cannot be disregarded. Regulation of TNBS retention time cannot be strictly controlled because of the wide variations in the duration and depth of anesthesia, especially if intraperitoneal anesthesia (IPA) is selected [14] . Therefore, the development of a novel approach to effectively regulate TNBS retention time is needed.
Compared with IPA, the use of inhalation anesthesia results in an improvement of the reliability of animal experiments because the depth of anesthesia can be more accurately controlled and maintained [14] . Sevoflurane is an anesthetic agent licensed for clinical use and can be used with standard vaporization techniques [15, 16] . Its low solubility in blood allows for precise and rapid changes in the depth of the anesthesia in addition to a fast induction and recovery, all properties which may be useful in animal research [15, 17] . Therefore, we hypothesized that the use of inhalation anesthesia with sevoflurane in the TNBS colitis induction model would decrease the dispersion of anesthesia time and retention time of TNBS administered into the colon.
We also hypothesized that rigid control of the time of enema exposure would achieve a more accurate uniformity of disease severity in the TNBS-induced colitis in mice. Thus, in the study reported here, we developed a modified method of creating a murine TNBS-induced colitis model in which the mice were anesthetized using continuous inhalation anesthesia (CIA) with sevoflurane, and the depth of anesthesia was controlled to efficiently retain TNBS enema in the inverted position. We evaluated the usefulness of this method using both single and repeated TNBS administrations and compared the results with those obtained with the conventional method using IPA with avertin.
Materials and Methods

Mice
Female C57BL/6J and BALB/c mice (age 9-10 weeks) were purchased from Japan SLC (Hamamatsu, Japan). The mice were housed under a constant 12/12-h dark/light cycle and were given standard chow and water ad libitum in an animal facility. Mice weighing 21-22 g at 10-12 weeks of age were used for this study.
Materials
The TNBS was purchased from Sigma-Aldrich (St. Louis, MO). Sevoflurane [fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether, SEVORANE) was purchased from Maruishi Pharmaceutical Co., Ltd, Osaka, Japan, 2.2.2-tribromoethanol was purchased from Sigma-Aldrich, and 2-methyl-2-butanol was obtained from Wako Pure Chemical Industries, Ltd, Osaka, Japan). All other chemicals were purchased from Sigma-Aldrich.
Continuous Inhalation Anesthesia with Sevoflurane
After fasting for 10 h, mice were anesthetized with 5 % sevoflurane in a Perspex induction chamber (11 9 30 9 10 cm). Sevoflurane in 100 % oxygen (flow rate 2-l/min) was delivered by a thermocompensated vaporizer (Ohmeda Sevotec 3; Abbott Laboratories, Abbott Park, North Chicago, IL; Fig. 1a ). After 6 min, all mice were quickly transferred into a continuous flow chamber (Fig. 1b) where they were kept in an inverted position with spontaneous breathing. Ten minutes after the induction of anesthesia, the concentration of sevoflurane was decreased to 4 %, and a TNBS enema was administered to induce colitis. The concentration of sevoflurane was decreased gradually according to the determined protocol (Table 1) . Sevoflurane concentration and anesthesia time were determined on the basis of the results of preliminary experiments so as to maximally retain TNBS enema. The anesthesia time was defined as the duration of time between the initiation of anesthesia and the ability to retain a hunched posture.
IPA with Avertin
Mice were anesthetized by the intraperitoneal (i.p.) injection of 2.5 % avertin (10 ll/g body weight). After being anesthetized, all mice were quickly transferred into a continuous flow chamber with 100 % oxygen (flow rate 2-l/min), where mice were kept in an inverted position while they breathed spontaneously. TNBS was then rectally administered to induce colitis.
TNBS-Induced Acute Colitis by Single Administration
To remove as much stool as possible, mice were fasted for 10 h prior to all experiments; water was provided ad libitum. The technique for TNBS-induced acute colitis as established by Markus et al. [9] was slightly modified in our study. Briefly, after well-balanced anesthesia, up to 2.25-3.375 mg of TNBS in 50-60 % ethanol was rectally administered on day 0. Mice were held in an inverted vertical position for at least 40 min in a continuous flow chamber (Fig. 1b, c) . Each dose was slowly administered into the lumen of the colon via a 3.5-F catheter equipped with a 1-ml syringe. The catheter tips were inserted to a depth of 5 cm from the anal ring, and a total volume of 150 ll of TNBS was administered. Control experiments were performed with 50 or 55 % ethanol alone. Body weights were recorded daily. The volume of excreted enema solution was carefully recorded each time. Thirty minutes after administration, each mouse was removed from the flow chamber, transferred to empty cages, and allowed to breathe spontaneously.
TNBS-Induced Chronic Colitis by Repeated Administrations
Chronic TNBS-induced colitis was induced by the administration of two incremental doses of TNBS in 55 % ethanol. The first dose of 2.25 mg was followed by a second dose of 3.375 mg 7 days later; both doses were given in a volume of 150 ll. TNBS retention time was at least 30 min in each experiment.
Macroscopic and Histological Examination
The animals were euthanized by i.p. injection of 2.5 % avertin at a lethal dose. The colons were removed intact from the anus to the ileocecal junction and the length measured; the colons were cleaned with phosphate-buffered saline (PBS). The resected colon was rolled, fixed in 10 % buffered formalin, and embedded in paraffin. The paraffin-embedded colon sections were cut and then stained with hematoxylin and eosin (H&E) or by the Masson's trichrome method. The distal 5 cm of the TNBStreated colons were used for macroscopic examination. Histological scoring was done according to the scoring scale as shown in Table 2 , which was modified to be suitable for our study from the scale of Valentin et al. [18] to ensure that the extent of inflammatory infiltrate and length of damaged area were examined impartially. Scoring of the infiltrate was assessed in the most widely affected area.
RNA Extraction and Real-Time RT-PCR for Cytokine Expression
Total RNA from colonic samples (5 cm proximal to the anus) was extracted using TRIzol Reagent (Sigma-Aldrich) according to the manufacturer's instructions. Reverse transcription (RT) was carried out using the GeneAmp Ò PCR System 9700 thermal cycler (Applied Biosystems, Foster City, CA) and the SuperScript Ò VIVO TM cDNA Synthesis kit (Invitrogen, Carlsbad, CA). Gene expression of IFN-c, TNF-a, IL-4, IL-10, IL-6, and IL-17A was quantitated by performing cDNA specific TaqMan Ò Gene Expression assays during the second step of a two-step RT-PCR; assay information is listed in Table 3 . Real-time quantitative PCR reactions after preamplification were performed using the 48.48 Dynamic Array chip on BioMark TM System (Fluidigm Corp., South San Francisco, CA). The amplification program consisted of one cycle at 95°C for 10 min, and 40 cycles of 95°C for 15 s and 60°C for 1 min. Data were analyzed using the Fluidigm Real-Time PCR Analysis Software 3.0.2. (Fluidigm Corp.). Cytokine expression normalized to 18S rRNA expression is represented as a fold change relative to the 18S rRNA expression in control mice.
Statistical Analysis
All data, with the exception of data given in Figs. 2 and 3d, are expressed as the mean ± standard error of the mean (SEM). The data given in Figs. 2 and 3d are expressed as the mean ± standard deviation (SD). Statistical significance was determined using the unpaired Student's t test for the two group analysis and analysis of variance (ANOVA) with post hoc comparisons by Dunnett's multiple comparison test for multiple group analysis. To assess the dispersion between two groups, we used an F test. Histological scores are expressed as the mean ± SD and compared using the Mann-Whitney U test. P values of \0.05 were considered statistically significant. Statistical analysis was performed using StatView 5.0 (SAS Institute Inc., Cary, NC).
Ethical Considerations
The study was performed according to the guidelines and regulations for Laboratory Animal Care of Hamamatsu University School of Medicine.
Results
Comparison of Anesthesia Time Between CIA with Sevoflurane and IPA with Avertin
To evaluate the precision of CIA with sevoflurane, we compared the dispersion of anesthesia time using this procedure with that using IPA with avertin. According to the protocol (Table 1) , the dispersion of anesthesia time, as assessed by an F test, was significantly shorter in mice administered CIA with sevoflurane than in those administered IPA with avertin; however, mean anesthesia time was not different between the two procedures (Fig. 2) . These data suggest that mice administered CIA with sevoflurane had a faster recovery even during long durations under anesthesia.
Comparison of TNBS Retention Time and Body
Weight Change Between the CIA and IPA Groups
Using CIA with sevoflurane, we attempted to establish a modified method of TNBS-induced colitis in order to strictly control the severity of colitis. As shown in Fig. 1b , the mice were kept inverted during anesthesia and the depth of anesthesia was simultaneously controlled to retain (Fig. 3a-c) . Dispersion of the nadir weight and of body weight on day 7, as assessed by an F test, was significantly smaller in the CIA group than in the IPA group (Fig. 3d) . To evaluate the differences histologically, colonic tissue sections were scored using the scoring system shown in Table 2 on day 7. The extent of infiltrate of mononuclear cells and amount of goblet cell mucin depletion were apparent in the CIA group, whereas these findings were limited in the IPA group. Furthermore, the score of bowel length was significantly higher in the CIA group than in the IPA group (Fig. 3e) .
Optimization of the Modified Method of TNBSInduced Colitis by Single Administration
In preliminary experiments, the increasing incidence of unfavorable complications, including death, was observed when we used [2.5 mg TNBS in 50 % ethanol (not shown); therefore, in following experiments we used the optimized dose of 2.25 mg. To optimize the conditions of the modified method of TNBS-induced colitis by single administration, we examined the concentration-dependent effects of ethanol. As shown in Fig. 4a , the mortality rate in the group of mice given 60 % ethanol reached 40 %, and additional unfavorable complications, such as partial necrosis and adhesion, were frequently observed (Fig. 4b) . Shortening of the colon length was observed in a concentration-dependent manner (Fig. 4c) . In contrast, no difference in the mortality rate was found in mice given 50 and 55 % ethanol. Therefore, the optimal doses for this method were found to be 2.25 mg of TNBS and 55 % ethanol. Using this combination, nadir weight loss was 84 ± 2.8 % (Fig. 5a) , and sufficient mucosal damage could be induced. We evaluated the cytokine profile of the colonic tissue in this optimized condition using the quantitative RT-PCR assay. On day 3, the colonic mRNA expression of TNF-a and IL-6 was significantly elevated. On day 7, mRNA expression of IFN-c, TNF-a, and IL-17A was elevated, whereas that of IL-6 was downregulated compared to day 3 (Fig. 5b) . Histological findings on day 3 showed distortion of crypts, loss of goblet cells, and presence of focal ulcers accompanied by edema in the mucosal or submucosal regions. By day 7, disrupted crypts and goblet cells were regenerated in most parts of the mucosa, but infiltration of mononuclear cells was still prominent in the stromal tissue of the basal mucosal areas (Fig. 5c, d) . The trichromestained collagen deposits were seen in the stromal tissue in the mucosa and submucosa on days 3 and 7, respectively. These findings were seen uniformly 5 cm proximal from the anus.
Comparison of Disease Severity Among Different TNBS Retention Time Groups Using CIA
To further confirm the reliability of our method, we examined whether disease severity could be controlled by changing the TNBS retention time in the colon. We established three different TNBS retention time groups of mice treated using our modified method of CIA, namely, 20, 35, and 50 min (Fig. 6c) . In this experiment, we used 2.5 mg of TNBS in 50 % ethanol in each group. The results showed that there was only a 15-min delay in TNBS enema excretion affecting the parameters of disease severity (Fig. 6a, d ). For example, the mortality rate was 0 % in the 20-min group, 23 % in the 35-min group, and 33 % in the 50-min group (Fig. 6b) . Unfavorable complications, such as partial necrosis and adhesion, also increased with increasing TNBS retention time (Fig. 6d) , and the average length of the colon decreased in a timedependent manner (9.65 cm in control mice; 8.11 cm in the 35-min group, P \ 0.05; 7.15 cm in the 50-min group, P \ 0.01; Fig. 6e ). These results show that TNBS retention time was closely correlated with disease severity using the same dose of TNBS or ethanol. We also demonstrated the reliability of our method to control TNBS retention time in this experiment.
Evaluation of the Repeated TNBS Administration Model Using CIA
Given that the utility of our method could be demonstrated using a single administration of TNBS, we next evaluated the feasibility of repeated administration of TNBS to mimic a chronic colitis model. The optimized protocol of repeated administration which was made according to our preliminary experiments is shown in Fig. 7a . Because repeated administration of TNBS enema seemed to induce relatively mild colitis in mice, escalation of the TNBS doses and shortening of the interval between doses were needed in our settings. According to our protocol, repeated administration was feasible without excessive mortality, and body weight loss was modest during the course of experiments (Fig. 7b) . Histological findings on day 17
Dig Dis Sci (2014) 59:1415-1427 1421 mimicked what was previously seen on day 7 in acute colitis, including mononuclear cell infiltration into the basal mucosal area, destruction of crypts, loss of goblet cells, and mucosal/submucosal edema (Fig. 7c, d ). Trichrome-stained collagen deposits were assessed to determine the level of fibrotic change following repeated administrations. Although the trichrome-stained collagen deposits were seen in the stromal tissue in mucosa and submucosa, no remarkable difference was observed between the single-and repeated-administration groups in this study (Fig. 7d) .
Discussion
In our study, we developed and tested a modified method of TNBS-induced colitis using CIA with sevoflurane that enables strict control of the severity of colitis and compared this model with IPA. The novelty of this system is that the mice can be kept in an inverted position during anesthesia and the depth of anesthesia can be simultaneously controlled to retain TNBS efficiently in the colon. Our main findings were as follows. First, compared with IPA, CIA decreased the dispersion of anesthesia time, decreased TNBS retention time, and decreased nadir weight during the course of TNBS-induced colitis. Second, optimization of the modified TNBS-induced colitis was attained by the administration of 2.25 mg TNBS in 55 % ethanol. Third, regulation of TNBS retention time by CIA enabled strict control of the disease severity of TNBS-induced colitis. Finally, a chronic colitis model by repeated TNBS administration was also established without excessive mortality of mice. These findings show that this system has an advantage in the TNBS-induced colitis model with both single and repeated TNBS administrations. Using the conventional protocol, TNBS enema is commonly retained in the colon for at least 30-60 s [5, 11, 12] followed by spontaneous evacuation. Thus, the final residual volume of the TNBS enema is different among the mice because of the dispersion of anesthesia time. The same problem of anal leakage of the TNBS enema has also been found in rats [19] . Compared with these conventional methods, our modified method using CIA enables the regulation of TNBS retention time.
The particular advantage of our method is that the mortality rate can be suppressed without decreasing the histological severity of the colitis. If the dose reduction is not taken into account, TNBS-induced colitis is generally associated with a high mortality rate [5, 6, 20, 21] . To avoid the loss of mice, researchers may need to decrease either the TNBS dose or the ethanol concentration [5] , which may result in insufficient histological changes. In our study, we demonstrated that a fixed time of exposure and an appropriate dose of TNBS could avoid any excessive mortality of mice, even when a high concentration of ethanol is used. A low volume of TNBS, such as 50 ll, has been the most commonly reported dose to induce TNBSinduced colitis in repeated administrations [22, 23] . In contrast, the aim of our method is to excrete a large volume as soon as possible after the exposure time, and we were able to regulate the final residual volume as a result.
We also evaluated the cytokine profile of the colonic tissue in an optimized condition of our modified method on days 3 and 7. On day 3, a nonspecific inflammatory response, characterized by a marked increase in IL-6 and TNF-a levels, was observed and considered to indicate an acute phase of TNBS-induced colitis. In comparison, on day 7 in particular, the responses of the T helper (Th) cells Th1-Th17, considered to indicate an established TNBSinduced colitis state (increase in IFN-c, TNF-a, and IL-17A), were observed. These responses of Th1-Th17 cells in TNBS-induced colitis were consistent with those reported earlier [24, 25] , and the reliability of our modified method was confirmed on the basis of immunological characteristics.
In previous reports, inhalation anesthesia, such as isoflurane [11, 26, 27] and methoxyflurane [9] , have been used in murine TNBS-induced colitis. However, our model differs from these methods in several ways. In our study, the duration of both inhalation anesthesia and TNBS retention time was fixed at a length sufficient to break the mucosal barrier and achieve widespread inflammation, whereas in previous [5, 11, 12] . Second, the depth of anesthesia in our method is appropriately controlled so as not to discharge the enema before the defined time point. Although the method of anesthesia is not always described in most studies of TNBSinduced colitis, such detailed condition settings for anesthesia as those described in our study could be advantageous in terms of decreasing the interindividual variability. C57BL/6J mice are known to be resistant to TNBSinduced colitis, unlike the SJL or BALB/c strains [5, 6, 28, 29] . Therefore, the concentration of administered TNBS enema tends to be higher in C57BL/6J mice than in BALB/ c mice [6] . However, the administration of high doses of TNBS might result in a high mortality rate in C57BL/6J mice [6, 28] . Our method involves a fixed time exposure of low doses of TNBS which results in the damage being only superficial without deep ulceration. Although we did not directly examine the effect of ethanol on mucosal integrity, high concentrations and a long exposure time to ethanol may help haptens penetrate the intestinal epithelial barrier.
In this study, we used C57BL/6J mice to compare our newly developed modified method of TNBS-induced colitis using CIA with a conventional method using IPA. We fully expected that our method would be applicable to other mouse strains. To confirm this, we also tried to produce TNBS-induced colitis in mice of the BALB/c strain following the anesthetic protocol optimized to this strain [Electronic Supplemental Material (ESM) Table 1 ]. We found that TNBS retention volume could be regulated and that the dispersion of body weight change could be controlled in a similar manner as in BALB/c mice. Histological findings on day 3 and day 7 were favorable, as expected (ESM Fig. 1 ). These results suggest that a modified method of TNBS-induced colitis using CIA is applicable not only to C57BL/6J mice but also to other mouse strains, although the optimized condition should be determined in each strain.
Chronic hapten-induced colitis in BALB/c mice by repeated administration of TNBS was first reported by Lawrance et al. [13] . There are only a few reports on repeated administration in BALB/c mice [11-13, 30, 31] and CD-1 outbred mice [32] . Moreover, there is only one article on the administration of TNBS in C57BL/6J mice [22] , and little information is available on the time course of body weight change. In a repeated administration model, fasting to limit the amount of stool in the colon can affect the condition of mice. Furthermore, if a slightly higher dose is administered by the i.p. or subcutaneous route, deep anesthesia can be too stressful and may have a serious impact on the results [14] . Although the inflammatory changes did not last for a long time in our experiment, we were able to show the utility of a repeated administration model in C57BL/6J mice and to present the time course of body weight change.
There are several limitations to our study. First, we did not use a TNBS presensitization solution in this study. Because presensitization results in significant TNBSinduced colitis even in a relatively resistant strain such as C57BL/6J mice [5] , the optimized conditions shown here might be changed if this step were to be utilized. Second, repeated administration in our experiments resulted in diminished mucosal damage, even in short intervals between administrations. Mild and transient breach in the epithelial barrier by 50 % ethanol has been reported to increase resistance to the subsequent induction of TNBSinduced colitis in SJL and C57BL10 mice [33] , and this also occurred in the mice used in our study.
Regardless of the limitations listed above, our established system of murine TNBS-induced colitis using inhalation anesthesia with sevoflurane was able to provide a more consistent induction of experimental colitis than that using IPA, in both single and repeated TNBS administrations. Given the advantages of this model, further studies could be carried out to evaluate the molecular mechanisms involved in IBD pathogenesis and potential therapeutic targets.
